Activation of-receptors induces binge-like drinking in sardinian alcohol-preferring rats

Neuropsychopharmacology

Volumn 36, Issue 6, 2011, Pages 1207-1218

  Sabino, Valentina ^a,b   Cottone, Pietro ^a,b   Blasio, Angelo ^b,d   Iyer, Malliga R ^c   Steardo, Luca ^d   Rice, Kenner C ^c   Conti, Bruno ^a   Koob, George F ^a   Zorrilla, Eric P ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

addiction and substance abuse; alcohol and alcoholism; alcohol OR ethanol; binge like OR binge; dependence; self administration

Indexed keywords

1,3 BIS(2 METHYLPHENYL)GUANIDINE; ALCOHOL; BD 1063; CYCLOPHILIN A; DELTA OPIATE RECEPTOR; MESSENGER RNA; MU OPIATE RECEPTOR; OPIATE AGONIST; OPIATE ANTAGONIST; SACCHARIN; SIGMA OPIATE RECEPTOR; SUCROSE; UNCLASSIFIED DRUG;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; DRUG SELF ADMINISTRATION; GENE EXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REINFORCEMENT; SOUTHERN EUROPE; VENTRAL TEGMENTUM; ANIMAL; BLOOD; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; RAT STRAIN;

ALCOHOL DRINKING; ALCOHOL-INDUCED DISORDERS, NERVOUS SYSTEM; ANIMALS; DISEASE MODELS, ANIMAL; ETHANOL; GENETIC PREDISPOSITION TO DISEASE; MALE; RATS; RATS, MUTANT STRAINS; RECEPTORS, SIGMA;

EID: 79954595670     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2011.5     Document Type: Article

References (104)

1. Ajmo Jr CT, Vernon DO, Collier L, Pennypacker KR, Cuevas J (2006). Sigma receptor activation reduces infarct size at 24 h after permanent middle cerebral artery occlusion in rats. Curr Neurovasc Res 3: 89-98. (Pubitemid 43778702)
2. Alonso G, Phan V, Guillemain I, Saunier M, Legrand A, Anoal M et al (2000). Immunocytochemical localization of the sigma (1) receptor in the adult rat central nervous system. Neuroscience 97: 155-170. (Pubitemid 30195885)
3. Ault DT, Radeff JM, Werling LL (1998). Modulation of [3H] Dopamine release from rat nucleus accumbens by neuropeptide Y may involve a sigma1-like receptor. J Pharmacol Exp Ther 284: 553-560. (Pubitemid 28086641)
4. Ault DT, Werling LL (1999). Phencyclidine and dizocilpine modulate dopamine release from rat nucleus accumbens via sigma receptors. Eur J Pharmacol 386: 145-153. (Pubitemid 30017705)
5. Aydar E, Palmer CP, Klyachko VA, Jackson MB (2002). The sigma receptor as a ligand-regulated auxiliary potassium channel subunit. Neuron 34: 399-410. (Pubitemid 34465498)
6. Bals-Kubik R, Shippenberg TS, Herz A (1990). Involvement of central mu and delta opioid receptors in mediating the reinforcing effects of beta-endorphin in the rat. Eur J Pharmacol 175: 63-69. (Pubitemid 20027649)
7. Bohman M, Sigvardsson S, Cloninger CR (1981). Maternal inheritance of alcohol abuse. Cross-fostering analysis of adopted women. Arch Gen Psychiatry 38: 965-969. (Pubitemid 11061222)
8. Bouchard P, Quirion R (1997). [3H]1,3-di(2-tolyl)guanidine and [3H](+)pentazocine binding sites in the rat brain: autoradio-graphic visualization of the putative sigma1 and sigma2 receptor subtypes. Neuroscience 76: 467-477. (Pubitemid 27008477)
9. Caine SB, Koob GF (1994). Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther 270: 209-218. (Pubitemid 24229630)
10. Ceci A, Smith M, French ED (1988). Activation of the A10 mesolimbic system by the sigma-receptor agonist (+)SKF 10047 can be blocked by rimcazole, a novel putative antipsychotic. Eur J Pharmacol 154: 53-57.
11. Chaki S, Okuyama S, Ogawa S, Tomisawa K (1998). Regulation of NMDA-induced [3H]dopamine release from rat hippocampal slices through sigma-1 binding sites. Neurochem Int 33: 29-34. (Pubitemid 28310713)
12. Cloninger CR, Bohman M, Sigvardsson S (1981). Inheritance of alcohol abuse. Cross-fostering analysis of adopted men. Arch Gen Psychiatry 38: 861-868. (Pubitemid 11040130)
13. Colombo G (1997). ESBRA-Nordmann 1996 Award Lecture: ethanol drinking behaviour in Sardinian alcohol-preferring rats. Alcohol Alcohol 32: 443-453. (Pubitemid 27361739)
14. Colombo G, Lobina C, Carai MA, Gessa GL (2006). Phenotypic characterization of genetically selected Sardinian alcohol-preferring (sP) and -non-preferring (sNP) rats. Addict Biol 11: 324-338. (Pubitemid 46696906)
15. Colombo G, Serra S, Brunetti G, Gomez R, Melis S, Vacca G et al (2002). Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats. Psychopharmacology (Berl) 159: 181-187. (Pubitemid 34146562)
16. Colombo G, Serra S, Vacca G, Carai MA, Gessa GL (2005). Endocannabinoid system and alcohol addiction: pharmacological studies. Pharmacol Biochem Behav 81: 369-380. (Pubitemid 40807134)
17. Cottone P, Sabino V, Roberto M, Bajo M, Pockros L, Frihauf JB et al (2009). CRF system recruitment mediates dark side of compulsive eating. Proc Natl Acad Sci USA 106: 20016-20020.
18. De Costa BR, He XS, Linders JT, Dominguez C, Gu ZQ, Williams W et al (1993). Synthesis and evaluation of conformationally restricted N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyr-rolidinyl)ethylamines at sigma receptors 2. Piperazines, bicyclic amines, bridged bicyclic amines, and miscellaneous compounds. J Med Chem 36: 2311-2320. (Pubitemid 23262462)
19. Deutsch JA, Walton NY (1977). Diazepam maintenance of alcohol preference during alcohol withdrawal. Science 198: 307-309. (Pubitemid 8209679)
20. Devine DP, Wise RA (1994). Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J Neurosci 14: 1978-1984. (Pubitemid 24108108)
21. Di Chiara G, Imperato A (1988a). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85: 5274-5278.
22. Di Chiara G, Imperato A (1988b). Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244: 1067-1080. (Pubitemid 18090131)
23. Fontanilla D, Johannessen M, Hajipour AR, Cozzi NV, Jackson MB, Ruoho AE (2009). The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science 323: 934-937.
24. Gilpin NW, Koob GF (2010). Effects of b-adrenoceptor antagonists on alcohol drinking by alcohol-dependent rats. Psychopharmacology (Berl) 212: 431-439.
25. Gonzalez-Alvear GM, Werling LL (1994). Regulation of [3H]dopamine release from rat striatal slices by sigma receptor ligands. J Pharmacol Exp Ther 271: 212-219.
26. Gosnell BA, Patel CK (1993). Centrally administered mu- and delta-opioid agonists increase operant responding for saccharin. Pharmacol Biochem Behav 45: 979-982.
27. Gronier B, Debonnel G (1999). Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotrans-mission in the dopaminergic systems. Eur J Pharmacol 368: 183-196. (Pubitemid 29117139)
28. Gudelsky GA (1999). Biphasic effect of sigma receptor ligands on the extracellular concentration of dopamine in the striatum of the rat. J Neural Transm 106: 849-856. (Pubitemid 29516054)
29. Gundlach AL, Largent BL, Snyder SH (1986). Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. J Neurosci 6: 1757-1770. (Pubitemid 16078351)
30. Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, Kempner E et al (1996). Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci USA 93: 8072-8077. (Pubitemid 26277167)
31. Hayashi T, Su TP (2003). Intracellular dynamics of sigma-1 receptors (sigma(1) binding sites) in NG108-15 cells. J Pharmacol Exp Ther 306: 726-733. (Pubitemid 36886174)
32. Hayashi T, Su TP (2007). Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 131: 596-610. (Pubitemid 350017760)
33. Hayashi T, Su TP (2008). An update on the development of drugs for neuropsychiatric disorders: focusing on the sigma1 receptor ligand. Expert Opin Ther Targets 12: 45-58. (Pubitemid 351247161)
34. Hellewell SB, Bowen WD (1990). A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain. Brain Res 527: 244-253. (Pubitemid 20289511)
35. Herrera Y, Katnik C, Rodriguez JD, Hall AA, Willing A, Pennypacker KR et al (2008). sigma-1 receptor modulation of acid-sensing ion channel a (ASIC1a) and ASIC1a-induced Ca2+ influx in rat cortical neurons. J Pharmacol Exp Ther 327: 491-502.
36. Herz A (1997). Endogenous opioid systems and alcohol addiction. Psychopharmacology (Berl) 129: 99-111. (Pubitemid 27033665)
37. Hiranita T, Soto PL, Tanda G, Katz JL (2010). Reinforcing effects of sigma-receptor agonists in rats trained to self-administer cocaine. J Pharmacol Exp Ther 332: 515-524.
38. Hiranita T, Tanda G, Kopajtic TA, Newman AH, Katz JL (2009). Reinforcing effects of sigma-receptor agonists in cocaine-experienced and naive rats. Program No 496.1: Neuroscience Meeting Planner Society for Neuroscience, Chicago, IL.
39. Iyengar S, Dilworth VM, Mick SJ, Contreras PC, Monahan JB, Rao TS et al (1990). Sigma receptors modulate both A9 and A10 dopaminergic neurons in the rat brain: functional interaction with NMDA receptors. Brain Res 524: 322-326. (Pubitemid 20260679)
40. Jarjour S, Bai L, Gianoulakis C (2009). Effect of acute ethanol administration on the release of opioid peptides from the midbrain including the ventral tegmental area. Alcohol Clin Exp Res 33: 1033-1043.
41. Kim FJ, Kovalyshyn I, Burgman M, Neilan C, Chien CC, Pasternak GW (2010). Sigma1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding. Mol Pharmacol 77: 695-703.
42. Krishnan-Sarin S, Jing SL, Kurtz DL, Zweifel M, Portoghese PS, Li TK et al (1995). The delta opioid receptor antagonist naltrindole attenuates both alcohol and saccharin intake in rats selectively bred for alcohol preference. Psychopharmacology (Berl) 120: 177-185.
43. Lasek AW, Janak PH, He L, Whistler JL, Heberlein U (2007). Downregulation of mu opioid receptor by RNA interference in the ventral tegmental area reduces ethanol consumption in mice. Genes Brain Behav 6: 728-735. (Pubitemid 350043944)
44. Le AD, Poulos CX, Quan B, Chow S (1993). The effects of selective blockade of delta and mu opiate receptors on ethanol consumption by C57BL/6 mice in a restricted access paradigm. Brain Res 630: 330-332. (Pubitemid 23342856)
45. Lever JR, Gustafson JL, Xu R, Allmon RL, Lever SZ (2006). Sigma1 and sigma2 receptor binding affinity and selectivity of SA4503 and fluoroethyl SA4503. Synapse 59: 350-358.
46. Lopez-Moreno JA, Gonzalez-Cuevas G, Navarro M (2007). The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol. Neurobiol Dis 25: 274-283. (Pubitemid 46124008)
47. Lopez-Moreno JA, Gonzalez-Cuevas G, Rodriguez de Fonseca F, Navarro M (2004). Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55 212-2 during alcohol deprivation. J Neurosci 24: 8245-8252. (Pubitemid 39280804)
48. Maldonado R, Robledo P, Chover AJ, Caine SB, Koob GF (1993). D1 dopamine receptors in the nucleus accumbens modulate cocaine self-administration in the rat. Pharmacol Biochem Behav 45: 239-242.
49. Mansour A, Fox CA, Akil H, Watson SJ (1995). Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18: 22-29.
50. Margolis EB, Fields HL, Hjelmstad GO, Mitchell JM (2008). Delta-opioid receptor expression in the ventral tegmental area protects against elevated alcohol consumption. J Neurosci 28: 12672-12681.
51. Martin-Fardon R, Maurice T, Aujla H, Bowen WD, Weiss F (2007). Differential effects of sigma1 receptor blockade on self-administration and conditioned reinstatement motivated by cocaine vs natural reward. Neuropsychopharmacology 32: 1967-1973. (Pubitemid 47258516)
52. Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976). The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197: 517-532.
53. Matsumoto RR, Bowen WD, Tom MA, Vo VN, Truong DD, De Costa BR (1995). Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism. Eur J Pharmacol 280: 301-310.
54. Matsumoto RR, Liu Y, Lerner M, Howard EW, Brackett DJ (2003). Sigma receptors: potential medications development target for anti-cocaine agents. Eur J Pharmacol 469: 1-12. (Pubitemid 36629544)
55. Matsumoto RR, Mack AL (2001). (+/-)-SM 21 attenuates the convulsive and locomotor stimulatory effects of cocaine in mice. Eur J Pharmacol 417: R1-R2. (Pubitemid 32299879)
56. Matsumoto RR, McCracken KA, Friedman MJ, Pouw B, De Costa BR, Bowen WD (2001). Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting sigma1 receptors produce anti-cocaine effects in mice. Eur J Pharmacol 419: 163-174. (Pubitemid 32568215)
57. Matsuno K, Matsunaga KH, Mita S (1995). Acute effects of sigma ligands on the extracellular DOPAC level in rat frontal cortex and striatum. Neurochem Res 20: 233-238.
58. Maurice T, Casalino M, Lacroix M, Romieu P (2003). Involvement of the sigma1 receptor in the motivational effects of ethanol in mice. Pharmacol Biochem Behav 74: 869-876. (Pubitemid 36355948)
59. Maurice T, Martin-Fardon R, Romieu P, Matsumoto RR (2002). Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity. Neurosci Biobehav Rev 26: 499-527. (Pubitemid 36158665)
60. Maurice T, Phan VL, Urani A, Kamei H, Noda Y, Nabeshima T (1999). Neuroactive neurosteroids as endogenous effectors for the sigma1 (sigma1) receptor: pharmacological evidence and therapeutic opportunities. Jpn J Pharmacol 81: 125-155. (Pubitemid 29532972)
61. Maurice T, Romieu P (2004). Involvement of the sigma1 receptor in the appetitive effects of cocaine. Pharmacopsychiatry 37(Suppl 3): S198-S207. (Pubitemid 39578129)
62. McBride WJ, Li TK (1998). Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit Rev Neurobiol 12: 339-369. (Pubitemid 29073864)
63. McBride WJ, Murphy JM, Ikemoto S (1999). Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav Brain Res 101: 129-152. (Pubitemid 29236359)
64. McCracken KA, Bowen WD, Matsumoto RR (1999). Novel sigma receptor ligands attenuate the locomotor stimulatory effects of cocaine. Eur J Pharmacol 365: 35-38. (Pubitemid 29070716)
65. Moebius FF, Burrows GG, Hanner M, Schmid E, Striessnig J, Glossmann H (1993). Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma1 binding site by photoaffinity labeling and ligand-directed antibodies. Mol Pharmacol 44: 966-971. (Pubitemid 23344962)
66. Moison D, De Deurwaerdere P, Cagnotto A, Marrazzo A, Prezzavento O, Ronsisvalle G et al (2003). Intrastriatal administration of sigma ligands inhibits basal dopamine release in vivo. Neuropharmacology 45: 945-953. (Pubitemid 37297920)
67. Nguyen EC, McCracken KA, Liu Y, Pouw B, Matsumoto RR (2005). Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies. Neuropharmacology 49: 638-645. (Pubitemid 41208285)
68. NIAAA (2004). NIAAA council approves definition of binge drinking. NIAAA Newsletter 3: 3.
69. Nielsen CK, Simms JA, Pierson HB, Li R, Saini SK, Ananthan S et al (2008). A novel delta opioid receptor antagonist, SoRI-9409, produces a selective and long-lasting decrease in ethanol consumption in heavy-drinking rats. Biol Psychiatry 64: 974-981.
70. Nuwayhid SJ, Werling LL (2006). Sigma(2) (sigma(2)) receptors as a target for cocaine action in the rat striatum. Eur J Pharmacol 535: 98-103.
71. Olszewski PK, Levine AS (2007). Central opioids and consumption of sweet tastants: when reward outweighs homeostasis. Physiol Behav 91: 506-512. (Pubitemid 47247783)
72. Prescott CA, Kendler KS (1999). Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins. Am J Psychiatry 156: 34-40. (Pubitemid 29034877)
73. Quirion R, Bowen WD, Itzhak Y, Junien JL, Musacchio JM, Rothman RB et al (1992). A proposal for the classification of sigma binding sites. Trends Pharmacol Sci 13: 85-86.
74. Rawls SM, Baron DA, Geller EB, Adler MW (2002). Sigma sites mediate DTG-evoked hypothermia in rats. Pharmacol Biochem Behav 73: 779-786. (Pubitemid 35246225)
75. Roberto M, Gilpin NW, O'Dell LE, Cruz MT, Morse AC, Siggins GR et al (2008). Cellular and behavioral interactions of gabapentin with alcohol dependence. J Neurosci 28: 5762-5771.
76. Rodd ZA, Melendez RI, Bell RL, Kuc KA, Zhang Y, Murphy JM et al (2004). Intracranial self-administration of ethanol within the ventral tegmental area of male Wistar rats: evidence for involvement of dopamine neurons. J Neurosci 24: 1050-1057. (Pubitemid 38177012)
77. Romieu P, Martin-Fardon R, Maurice T (2000). Involvement of the sigma1 receptor in the cocaine-induced conditioned place preference. Neuroreport 11: 2885-2888.
78. Romieu P, Meunier J, Garcia D, Zozime N, Martin-Fardon R, Bowen WD et al (2004). The sigma1 (sigma1) receptor activation is a key step for the reactivation of cocaine conditioned place preference by drug priming. Psychopharmacology (Berl) 175: 154-162. (Pubitemid 39222345)
79. Romieu P, Phan VL, Martin-Fardon R, Maurice T (2002). Involvement of the sigma(1) receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade. Neuropsychopharmacology 26: 444-455. (Pubitemid 34260994)
80. Ruegg H, Yu WZ, Bodnar RJ (1997). Opioid-receptor subtype agonist-induced enhancements of sucrose intake are dependent upon sucrose concentration. Physiol Behav 62: 121-128. (Pubitemid 27303773)
81. Sabino V, Cottone P, Koob GF, Steardo L, Lee MJ, Rice KC et al (2006). Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. Psychopharmacology (Berl) 189: 175-186. (Pubitemid 44691540)
82. Sabino V, Cottone P, Steardo L, Schmidhammer H, Zorrilla EP (2007). 14-Methoxymetopon, a highly potent mu opioid agonist, biphasically affects ethanol intake in Sardinian alcohol-preferring rats. Psychopharmacology (Berl) 192: 537-546. (Pubitemid 46870748)
83. Sabino V, Cottone P, Zhao Y, Iyer MR, Steardo Jr L., Steardo L et al (2009a). The sigma-receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinking. Neuropsychopharmacology 34: 1482-1493.
84. Sabino V, Cottone P, Zhao Y, Steardo L, Koob GF, Zorrilla EP (2009b). Selective reduction of alcohol drinking in Sardinian alcohol-preferring rats by a sigma-1 receptor antagonist. Psychopharmacology (Berl) 205: 327-335.
85. Sanchez-Arroyos R, Guitart X (1999). Electrophysiological effects of E-5842, a sigma1 receptor ligand and potential atypical antipsychotic, on A9 and A10 dopamine neurons. Eur J Pharmacol 378: 31-37. (Pubitemid 29341560)
86. Sigvardsson S, Bohman M, Cloninger CR (1996). Replication of the Stockholm Adoption Study of alcoholism. Confirmatory cross-fostering analysis. Arch Gen Psychiatry 53: 681-687. (Pubitemid 26269328)
87. Skuza G, Kolasiewicz W (2001). Repeated treatment with SA4503, a selective sigma1 receptor agonist, up-regulates alpha-adrenergic system. a behavioral study. Pol J Pharmacol 53: 547-550. (Pubitemid 33138840)
88. Skuza G, Rogóz Z (2007). Antidepressant-like effect of combined treatment with selective sigma receptor agonists and a 5-HT1A receptor agonist in the forced swimming test in rats. Pharmacol Rep 59: 773-777. (Pubitemid 351586571)
89. Spanagel R, Herz A, Shippenberg TS (1990a). The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem 55: 1734-1740.
90. Spanagel R, Herz A, Shippenberg TS (1990b). Identification of the opioid receptor types mediating beta-endorphin-induced alterations in dopamine release in the nucleus accumbens. Eur J Pharmacol 190: 177-184. (Pubitemid 20372320)
91. Su TP (1993). Delineating biochemical and functional properties of sigma receptors: emerging concepts. Crit Rev Neurobiol 7: 187-203.
92. Su TP, Hayashi T (2003). Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. Curr Med Chem 10: 2073-2080. (Pubitemid 37139064)
93. Takahashi S, Miwa T, Horikomi K (2000). Involvement of sigma1 receptors in methamphetamine-induced behavioral sensitization in rats. Neurosci Lett 289: 21-24. (Pubitemid 30433836)
94. Tanda G, Garces-Ramirez L, Green JL, Hiranita T, Katz JL (2009). Neurochemical effects of sigma receptor agonists: A dopamine-microdialysis study in rats. Program No 496.4: Neuroscience Meeting Planner Society for Neuroscience, Chicago, IL.
95. Thompson TL, Bridges S, Miller C (2001). Modulation of dopa-mine uptake in rat nucleus accumbens: effect of specific dopamine receptor antagonists and sigma ligands. Neurosci Lett 312: 169-172. (Pubitemid 32972150)
96. Ukai M, Mori E, Kameyama T (1997). Modulatory effects of morphine, U-50488H and 1,3-di-(2-tolyl)guanidine on cocainelike discriminative stimulus in the rat using two-choice discrete-trial avoidance paradigm. Methods Find Exp Clin Pharmacol 19: 541-546. (Pubitemid 28011196)
97. Walker BM, Koob GF (2007). The g-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats. Alcohol Clin Exp Res 31: 11-18. (Pubitemid 46025360)
98. Walker BM, Rasmussen DD, Raskind MA, Koob GF (2008). alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol. Alcohol 42: 91-97. (Pubitemid 351389731)
99. Walker JM, Bowen WD, Walker FO, Matsumoto RR, De CB, Rice KC (1990). Sigma receptors: biology and function. Pharmacol Rev 42: 355-402.
100. Weatherspoon JK, Gonzalez-Alvear GM, Frank AR, Werling LL (1996). Regulation of [3H] dopamine release from mesolimbic and mesocortical areas of guinea pig brain by sigma receptors. Schizophr Res 21: 51-62. (Pubitemid 26291900)
101. Weiser SD, Patrick SL, Mascarella SW, Downing-Park J, Bai X, Carroll FI et al (1995). Stimulation of rat striatal tyrosine hydroxylase activity following intranigral administration of sigma receptor ligands. Eur J Pharmacol 275: 1-7.
102. Wise RA, Hoffman DC (1992). Localization of drug reward mechanisms by intracranial injections. Synapse 10: 247-263.
103. Zhang J, Chiodo LA, Wettstein JG, Junien JL, Freeman AS (1993). Repeated administration of Sigma ligands alters the population activity of rat midbrain dopaminergic neurons. Synapse 13: 223-230. (Pubitemid 23098074)
104. Zhang M, Kelley AE (2002). Intake of saccharin, salt, and ethanol solutions is increased by infusion of a mu opioid agonist into the nucleus accumbens. Psychopharmacology (Berl) 159: 415-423. (Pubitemid 34143366)